Aarti Pharmalabs Limited has informed the Exchange regarding Allotment of 6600 Shares.
AARTIPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Pharmalabs has allotted 6,600 equity shares to eligible employees under its Performance Stock Option Plan 2023 (PSOP 2023). The shares were issued at an exercise price of Rs. 5 each (face value, with no premium). After this allotment, the total paid-up equity share capital stands at Rs. 45.32 crore, comprising 9.06 crore equity shares of Rs. 5 face value. The newly issued shares will rank equally with existing shares and have no lock-in restrictions. This is a routine ESOP-related disclosure filed under SEBI regulations.
This is a very small dilution (6,600 shares out of over 9 crore), so it has negligible impact on shareholding or stock price. It signals normal employee compensation activity with no material financial implication for shareholders.